How a CRO approaches technology investment is an excellent way to evaluate its priorities & commitment to strategic innovation. We discuss why starting with study requirements is the best way to decide which #bioanalytical platforms to acquire: https://t.co/HceH7tcfb7

BioAgilytix remains committed to diversity as our global growth accelerates. Read how in our latest press release: https://t.co/8lm4LiFxEe

Checkpoint blockade immunotherapy provided significant improvements in overall survival for patients with melanoma brain metastases, according to researchers at @BrighamWomens. Read more via @GENbio: https://t.co/HW2sD2TSt7

BioAgilytix Europe is looking for a Quality Assurance Manager to join our team of professionals in Hamburg, Germany and support innovative biologics through quality output. #Apply today: https://t.co/AGgFEME8jj